|
1
|
Egidi MG, Cochetti G, Serva MR, Guelfi G,
Zampini D, Mechelli L and Mearini E: Circulating microRNAs and
kallikreins before and after radical prostatectomy: Are they really
prostate cancer markers? Biomed Res Int. 2013:2417802013.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Pan J, Xue W, Sha J, Yang H, Xu F, Xuan H,
Li D and Huang Y: Incidental prostate cancer at the time of
cystectomy: The incidence and clinicopathological features in
Chinese patients. PLoS One. 9:e944902014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wong MC, Goggins WB, Wang HH, Fung FD,
Leung C, Wong SY, Ng CF and Sung JJ: Global incidence and mortality
for prostate cancer: Analysis of temporal patterns and trends in 36
countries. Eur Urol. 70:862–874. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kahraman T, Cubuk R, Sinanoglu O, Tasalı
N, Ozarar M and Saydam B: Comparison of power Doppler ultrasound
with gray scale transrectal ultrasound in predicting cancer
positive prostate biopsy cores. Eurasian J Med. 42:81–85. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Guelfi G, Cochetti G, Stefanetti V,
Zampini D, Diverio S, Boni A and Mearini E: Next generation
sequencing of urine exfoliated cells: An approach of prostate
cancer microRNAs research. Sci Rep. 8:71112018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang J, Ma M, Nan X and Sheng B: Obesity
inversely correlates with prostate-specific antigen levels in a
population with normal screening results of prostate cancer in
northwestern China. Braz J Med Biol Res. 49(pii):
S0100–879X2016000800704. 2016.
|
|
8
|
Kaufmann S, Kruck S, Kramer U, Gatidis S,
Stenzl A, Roethke M, Scharpf M and Schilling D: Direct comparison
of targeted MRI-guided biopsy with systematic transrectal
ultrasound-guided biopsy in patients with previous negative
prostate biopsies. Urol Int. 94:319–325. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Baco E, Ukimura O, Rud E, Vlatkovic L,
Svindland A, Aron M, Palmer S, Matsugasumi T, Marien A, Bernhard
JC, et al: Magnetic resonance imaging-transectal ultrasound
image-fusion biopsies accurately characterize the index tumor:
Correlation with step-sectioned radical prostatectomy specimens in
135 patients. Eur Urol. 67:787–794. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cochetti G, Poli G, Guelfi G, Boni A,
Egidi MG and Mearini E: Different levels of serum microRNAs in
prostate cancer and benign prostatic hyperplasia: Evaluation of
potential diagnostic and prognostic role. Onco Targets Ther.
9:7545–7553. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang Q, Wang W, Zhang B, Shi J, Fu Y, Li
D, Guo S, Zhang S, Huang H, Jiang X, et al: Comparison of free-hand
transperineal mpMRI/TRUS fusion-guided biopsy with transperineal
12-core systematic biopsy for the diagnosis of prostate cancer: A
single-center prospective study in China. Int Urol Nephrol.
49:439–448. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Siddiqui MM, Rais-Bahrami S, Turkbey B,
George AK, Rothwax J, Shakir N, Okoro C, Raskolnikov D, Parnes HL,
Linehan WM, et al: Comparison of MR/ultrasound fusion-guided biopsy
with ultrasound-guided biopsy for the diagnosis of prostate cancer.
JAMA. 313:390–397. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Borkowetz A, Platzek I, Toma M, Laniado M,
Baretton G, Froehner M, Koch R, Wirth M and Zastrow S: Comparison
of systematic transrectal biopsy to transperineal magnetic
resonance imaging/ultrasound-fusion biopsy for the diagnosis of
prostate cance. BJU Int. 116:873–879. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Pepe P, Garufi A, Priolo G and Pennisi M:
Can MRI/TRUS fusion targeted biopsy replace saturation prostate
biopsy in the re-evaluation of men in active surveillance? World J
Urol. 34:1249–1253. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lian H, Zhuang J, Wang W, Zhang B, Shi J,
Li D, Fu Y, Jiang X, Zhou W and Guo H: Assessment of free-hand
transperineal targeted prostate biopsy using multiparametric
magnetic resonance imaging-transrectal ultrasound fusion in Chinese
men with prior negative biopsy and elevated prostate-specific
antigen. BMC Urol. 17:522017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ezquer A, Ortega Hrescak MC, Sanagua C,
Roggia-Rebullida P, López R, Cenice F, Veglia FH, Veglia F and
Fernández A: Transrectal doppler ultrasound during prostate biopsy:
Clinical utility and limitations. Actas Urol Esp. 39:13–19.
2015.(In English, Spanish). View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cochetti G, Boni A, Barillaro F, Pohja S,
Cirocchi R and Mearini E: Full neurovascular sparing
extraperitoneal robotic radical prostatectomy: Our experience with
PERUSIA technique. J Endourol. 31:32–37. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Boni A, Cochetti G, Del Zingaro M,
Paladini A, Turco M, Rossi de Vermandois JA and Mearini E: Uroflow
stop test with electromyography: A novel index of urinary
continence recovery after RARP. Int Urol Nephrol. 51:609–615. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhu G and Wang Q: Comparisons between
magnetic resonance/ultrasound fusion-guided biopsy and standard
biopsy in the diagnosis of prostate cancer: A prospective cohort
study. Medicine (Baltimore). 97:e119622018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Huang M, Lin Y, Xu A, Uhlman M, Deng X,
Lin X, Wu S, Diao P, Xie K and Tang P: Percent free
prostate-specific antigen does not improve the effectiveness of
prostate cancer detection in Chinese men with a prostate-specific
antigen of 2.5–20.0 ng/ml: A multicenter study. Med Oncol.
31:9252014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Mariotti GC, Falsarella PM, Garcia RG,
Queiroz MRG, Lemos GC and Baroni RH: Incremental diagnostic value
of targeted biopsy using mpMRI-TRUS fusion versus 14-fragments
prostatic biopsy: A prospective controlled study. Eur Radiol.
28:11–16. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Equator Network, . The Standards for
Reporting of Diagnostic accuracy studies guidelines. http://www.equator-network.org/reporting-guidelines/stard/September
6–2019
|
|
23
|
Barentsz JO, Richenberg J, Clements R,
Choyke P, Verma S, Villeirs G, Rouviere O, Logager V and Fütterer
JJ; European Society of Urogenital Radiology, : ESUR prostate MR
guidelines 2012. Eur Radiol. 22:746–757. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Rosenkrantz AB, Kim S, Lim RP, Hindman N,
Deng FM, Babb JS and Taneja SS: Prostate cancer localization using
multiparametric MR imaging: Comparison of prostate imaging
reporting and data system (PI-RADS) and Likert scales. Radiology.
269:482–492. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Costa DN, Lotan Y, Rofsky NM, Roehrborn C,
Liu A, Hornberger B, Xi Y, Francis F and Pedrosa I: Assessment of
prospectively assigned Likert scores for targeted magnetic
resonance imaging-transrectal ultrasound fusion biopsies in
patients with suspected prostate cancer. J Urol. 195:80–87. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Moore CM, Kasivisvanathan V, Eggener S,
Emberton M, Fütterer JJ, Gill IS, Grubb Iii RL, Hadaschik B, Klotz
L, Margolis DJ, et al: Standards of reporting for MRI-targeted
biopsy studies (START) of the prostate: Recommendations from an
International working group. Eur Urol. 64:544–552. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Dell'atti L: Prostatic abscess after
transrectal ultrasound-guided prostate biopsy. Case report. G Chir.
39:260–262. 2013.
|
|
28
|
Ozok HU, Sagnak L, Tuygun C, Oktay M,
Karakoyunlu N, Ersoy H and Alper M: Will the modification of the
Gleason grading system affect the urology practice? Int J Surg
Pathol. 18:248–254. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Labanaris AP, Witt JH and Zugor V:
Robotic-assisted radical prostatectomy in men ≥75 years of age.
Surgical, oncological and functional outcomes. Anticancer Res.
32:2085–2089. 2012.PubMed/NCBI
|
|
30
|
Agha RA, Borrelli MR, Vella-Baldacchino M,
Thavayogan R and Orgill DP; STROCSS Group, : The STROCSS statement:
Strengthening the reporting of Cohort studies in surgery. Int J
Surg. 46:198–202. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Fitzgerald M, Saville BR and Lewis RJ:
Decision curve analysis. JAMA. 13:409–410. 2015. View Article : Google Scholar
|
|
32
|
Bjurlin MA, Mendhiratta N, Wysock JS and
Taneja SS: Multiparametric MRI and targeted prostate biopsy:
Improvements in cancer detection, localization, and risk
assessment. Cent European J Urol. 69:9–18. 2016.PubMed/NCBI
|
|
33
|
Tan CH, Hobbs BP, Wei W and Kundra V:
Dynamic contrast-enhanced MRI for the detection of prostate cancer:
Meta-analysis. Am J Roentgenol. 204:W439–W448. 2015. View Article : Google Scholar
|
|
34
|
Sohail SK, Sarfraz R, Imran M, Khan NA and
Yusuf NW: Power doppler ultrasonography guided and random prostate
biopsy in prostate cancer diagnosis-a comparative study. J Pak Med
Assoc. 65:65–68. 2015.PubMed/NCBI
|
|
35
|
Delgado Oliva F, Arlandis Guzman S,
Bonillo García M, Broseta Rico E and Boronat Tormo F: Diagnostic
performance of power doppler and ultrasound contrast agents in
early imaging-based diagnosis of organ-confined prostate cancer: Is
it possible to spare cores with contrast-guided biopsy? Eur J
Radiol. 85:1778–1785. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Na YQ, Ye ZQ, Sun YH and Sun G: Chinese
Guidelines on Urologic DiseasesPR China Helath Department. People's
Medical Publishing House; Beijing: 2015, (In Chinese).
|
